| Record ID | marc_records_scriblio_net/part21.dat:64785444:1530 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part21.dat:64785444:1530?format=raw |
LEADER: 01530cam 2200361 a 4500
001 90010029
003 DLC
005 20040413180155.0
008 900611s1990 enka b 101 0 eng c
010 $a 90010029
020 $a0387196285 (New York : alk. paper)
020 $a3540196285 (Berlin : alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC931.O73$bH77 1990
060 $aWE 250 H873 1990
082 00 $a616.7/16$220
245 00 $aHRT and osteoporosis /$cedited by J.O. Drife and J.W.W. Studd.
260 $aLondon ;$aNew York :$bSpringer-Verlag,$cc1990.
300 $axvi, 394 p. :$bill. ;$c25 cm.
500 $aBased on the 22nd Study Group of the Royal College of Obstetricians and Gynaecologists held in January 1990; sponsored by Ciba-Geigy Pharmaceuticals and others.
504 $aIncludes bibliographical references and index.
650 0 $aOsteoporosis in women$xHormone therapy$vCongresses.
650 0 $aOsteoporosis in women$xHormone therapy$xComplications$vCongresses.
650 0 $aOlder women$xDiseases$vCongresses.
650 2 $aEstrogen Replacement Therapy$xcongresses.
650 2 $aMenopause$xcongresses.
650 2 $aOsteoporosis$xdrug therapy$xcongresses.
650 2 $aOsteoporosis$xetiology$xcongresses.
650 2 $aOsteoporosis$xprevention & control$xcongresses.
700 1 $aDrife, James O.,$d1947-
700 1 $aStudd, John.
710 2 $aGeigy Pharmaceuticals.
710 2 $aRoyal College of Obstetricians and Gynaecologists (Great Britain).$bStudy Group$n(22nd :$d1990)